Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Population-based prevalence of CDKN2A mutations in Utah melanoma families.

The Journal of investigative dermatology - 1 Mar 2006

Eliason Mark J, Larson April A, Florell Scott R, Zone John J, Cannon-Albright Lisa A, Samlowski Wolfram E, Leachman Sancy A

Abstract excerpt

Cyclin-dependent kinase inhibitor 2A (CDKN2A or p16) is the major melanoma predisposition gene. In order to evaluate the candidacy for genetic testing of CDKN2A mutations among melanoma prone families, it is important to identify characteristics that predict a high likelihood of carrying a CDKN2A mutation. We primarily used a unique Utah genealogical resource to identify independent melanoma prone families whom...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Neoplasms, Multiple Primary
Share to Base Sequence

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to CpG Islands

Share to Cyclin-Dependent Kinase Inhibitor p16

Share to Melanoma

Share to Molecular Sequence Data

Share to Pancreatic Neoplasms

Share to Skin Neoplasms

Source

Identifiers

PMID: 16397522
DOI: 10.1038/sj.jid.5700094

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Population-based prevalence of CDKN2A mutations in Utah melanoma families.PMID 16397522Read ↗

New developments in melanoma genetics.Semantic proximity Read ↗

CDKN2A Gene Mutations: Implications for Hereditary Cancer SyndromesSemantic proximity Read ↗

Phenocopies in melanoma-prone families with germ-line CDKN2A mutations.Semantic proximity Read ↗

Dermatologic surveillance in healthy carriers of CDKN2A and p.E318K MITF germline variants from melanoma-prone families: a 14 years hospital-based experience.Semantic proximity Read ↗

Noncoding germline mutations in p16/CDKN2A in melanoma-prone families.Semantic proximity Read ↗

CDKN2A germline mutations in individuals with cutaneous malignant melanoma.Semantic proximity Read ↗

Genotype-phenotype relationships in U.S. melanoma-prone families with CDKN2A and CDK4 mutations.Semantic proximity Read ↗

CDKN2A genetic testing in melanoma-prone families in Sweden in the years 2015-2020: implications for novel national recommendations.Semantic proximity Read ↗

Increased prevalence of lung, breast, and pancreatic cancers in addition to melanoma risk in families bearing the cyclin-dependent kinase inhibitor 2A mutation: implications for genetic counseling.Semantic proximity Read ↗

Low prevalence of germline CDKN2A and CDK4 mutations in patients with early-onset melanoma.Semantic proximity Read ↗

Prevalence of germ-line mutations in p16, p19ARF, and CDK4 in familial melanoma: analysis of a clinic-based population.Semantic proximity Read ↗

Clinical germline genetic testing for melanoma.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.